GGFG-PAB-Exatecan TFA is a drug-linker conjugate designed for antibody-drug conjugate (ADC) synthesis, combining the potent topoisomerase I inhibitor Exatecan with a cleavable GGFG-PAB linker. This construct is utilized in research for developing targeted cancer therapies and has been evaluated in both in vitro and in vivo preclinical studies.
Molekulargewicht:
1016.95
Formel:
C49H48F4N8O12
Target-Kategorie:
Topoisomerase,Drug-Linker Conjugates for ADC
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
